Foxx Life Sciences 5647012D New product! New type Borosil Volumetric Class A Flasks $88 Foxx Life Sciences 5647012D Borosil Flasks, Volumetric, Class A, Industrial Scientific Lab Scientific Products Glassware Labware $88 Foxx Life Sciences 5647012D Borosil Flasks, Volumetric, Class A, Industrial Scientific Lab Scientific Products Glassware Labware Industrial Scientific , Lab Scientific Products , Glassware Labware,Borosil,Flasks,,5647012D,Volumetric,,/kraken446046.html,www.3348southstreet.com,Life,Sciences,A,,Foxx,Class,$88 Foxx Life Sciences 5647012D New product! New type Borosil Volumetric Class A Flasks Industrial Scientific , Lab Scientific Products , Glassware Labware,Borosil,Flasks,,5647012D,Volumetric,,/kraken446046.html,www.3348southstreet.com,Life,Sciences,A,,Foxx,Class,$88

Foxx Life Sciences Brand Cheap Sale Venue 5647012D New product type Borosil Volumetric Class A Flasks

Foxx Life Sciences 5647012D Borosil Flasks, Volumetric, Class A,

$88

Foxx Life Sciences 5647012D Borosil Flasks, Volumetric, Class A,

|||

Product description

Borosil® flasks, volumetric, Class A, wm, clear, glass ST., 50Ml, 14/23, Designed Cert, 10/cs. Manufactured from 3.3 borosilicate, USP Type I Glass.

Foxx Life Sciences 5647012D Borosil Flasks, Volumetric, Class A,

Editor's Picks

COVID-19 in Quebec

STAY CONNECTED

MONTREAL ELECTION

Highlights from Across Canada

CTVNews.ca Top Stories

Queen Elizabeth II, 95, is advised to rest for 2 weeks

Queen Elizabeth II has been advised to rest for at least the next two weeks, accepting doctors' recommendations to take on only light duties and not travel, Buckingham Palace said Friday. The decision comes days after the 95-year-old sovereign underwent medical tests and spent the night at London's King Edward VII's Hospital, her first such stay in in eight years.

NACI names several more groups who should qualify for COVID-19 booster shots

The National Advisory Committee on Immunization has expanded eligibility guidelines for booster shots of COVID-19 vaccines. The committee now recommends mRNA boosters to people who received two doses of the Oxford-AstraZeneca vaccine, adults over the age of 70, front-line health-care workers with a short interval between their first two doses, and people from First Nations, Inuit and Metis communities.

LISTEN LIVE